The Trend of Age-Group Effect on Prognosis in Differentiated Thyroid Cancer

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Shi, Rong Liang ^a,b   Qu, Ning ^a   Liao, Tian ^a   Wei, Wen Jun ^a   Wang, Yu Long ^a   Ji, Qing Hai ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; AGED; CANCER REGISTRY; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; ONSET AGE; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SECONDARY; THYROID TUMOR; YOUNG ADULT;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEER PROGRAM; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84976349196     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27086     Document Type: Article

References (30)

1. Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA Cancer J Clin 64, 9-29, doi: 10.3322/caac.21208 (2014).
2. Gilliland, F. D., Hunt, W. C., Morris, D. M. & Key, C. R. Prognostic factors for thyroid carcinoma. A population-based study of 15, 698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer 79, 564-573 (1997).
3. Cady, B. et al. Risk factor analysis in differentiated thyroid cancer. Cancer 43, 810-820 (1979).
4. Navarro Silvera, S. A., Miller, A. B. & Rohan, T. E. Risk factors for thyroid cancer: A prospective cohort study. Int J Cancer 116, 433-438, doi: 10.1002/ijc.21079 (2005).
5. Sokic, S. I. et al. Risk factors for thyroid cancer. Neoplasma 41, 371-374 (1994).
6. Nikiforov, Y. E. & Fagin, J. A. Risk factors for thyroid cancer. Trends Endocrinol Metab 8, 20-25 (1997).
7. Rosen, I. B., Bowden, J., Luk, S. C. & Simpson, J. A. Aggressive thyroid cancer in low-risk age population. Surgery 102, 1075-1080 (1987).
8. Coburn, M. C. & Wanebo, H. J. Age correlates with increased frequency of high risk factors in elderly patients with thyroid cancer. Am J Surg 170, 471-475 (1995).
9. Sobin LH, G. M., Wittekind & CH. UICC: TNM classification of malignant tumors, 7th ed. New York: Wiley-Liss. 58-62 (2009).
10. Edge, S. B. & Compton, C. C. The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of surgical oncology 17, 1471-1474, doi: 10.1245/s10434-010-0985-4 (2010).
11. Passler, C. et al. Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution. Ann Surg 237, 227-234, doi: 10.1097/01.SLA.0000048449.69472.81 (2003).
12. Lang, B. H., Lo, C. Y., Chan, W. F., Lam, K. Y. & Wan, K. Y. Staging systems for papillary thyroid carcinoma: A review and comparison. Ann Surg 245, 366-378, doi: 10.1097/01.sla.0000250445.92336.2a (2007).
13. Tran Cao, H. S., Johnston, L. E., Chang, D. C. & Bouvet, M. A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the Surveillance, Epidemiology, and End Results (SEER) registry. Surgery 152, 145-151, doi: 10.1016/j.surg.2012.02.015 (2012).
14. Warren, J. L., Klabunde, C. N., Schrag, D., Bach, P. B. & Riley, G. F. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40, IV-3-18, doi: 10.1097/01.MLR.0000020942.47004.03 (2002).
15. Puskas, C. & Schober, O. [Adjuvant percutaneous radiation of locally advanced papillary and follicular thyroid carcinoma: reflections for the necessity of a prospective multicenter study]. Nuklearmedizin 38, 328-332 (1999).
16. Lerch, H., Schober, O., Kuwert, T. & Saur, H. B. Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 15, 2067-2075 (1997).
17. Hannequin, P., Liehn, J. C. & Delisle, M. J. Multifactorial analysis of survival in thyroid cancer. Pitfalls of applying the results of published studies to another population. Cancer 58, 1749-1755 (1986).
18. Mazzaferri, E. L. Management of low-risk differentiated thyroid cancer. Endocr Pract 13, 498-512, doi: 10.4158/EP.13.5.498 (2007).
19. Vianello, F. et al. Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation. Clin Oncol (R Coll Radiol) 24, 162-168, doi: 10.1016/j. clon.2011.02.011 (2012).
20. Shi, X. et al. Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants. J Clin Endocrinol Metab 101, 264-274, doi: 10.1210/jc.2015-2917 (2016).
21. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2015. CA Cancer J Clin 65, 5-29, doi: 10.3322/caac.21254 (2015).
22. Schlumberger, M. et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 37, 598-605 (1996).
23. Lang, B. H., Chow, S. M., Lo, C. Y., Law, S. C. & Lam, K. Y. Staging systems for papillary thyroid carcinoma: A study of 2 tertiary referral centers. Ann Surg 246, 114-121, doi: 10.1097/01.sla.0000262785.46403.9b (2007).
24. Shaha, A. R., Loree, T. R. & Shah, J. P. Intermediate-risk group for differentiated carcinoma of thyroid. Surgery 116, 1036-1040; discussion 1040-1031 (1994).
25. Beenken, S. et al. Extent of surgery for intermediate-risk well-differentiated thyroid cancer. Am J Surg 179, 51-56 (2000).
26. Brennan, M. D., Bergstralh, E. J., van Heerden, J. A. & McConahey, W. M. Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 66, 11-22 (1991).
27. Suman, P. et al. Risk factors for central lymph node metastasis in papillary thyroid carcinoma: A National Cancer Data Base (NCDB) study. Surgery 159, 31-40, doi: 10.1016/j.surg.2015.08.032 (2016).
28. Stansifer, K. J., Guynan, J. F., Wachal, B. M. & Smith, R. B. Modifiable risk factors and thyroid cancer. Otolaryngol Head Neck Surg 152, 432-437, doi: 10.1177/0194599814564537 (2015).
29. Biliotti, G. C. et al. Specific features of differentiated thyroid carcinoma in patients over 70 years of age. J Surg Oncol 93, 194-198, doi: 10.1002/jso.20512 (2006).
30. Lundgren, C. I., Hall, P., Dickman, P. W. & Zedenius, J. Clinically significant prognostic factors for differentiated thyroid carcinoma: A population-based, nested case-control study. Cancer 106, 524-531, doi: 10.1002/cncr.21653 (2006).